Time spent on PAs Time spent with patients Impact on Patients and Physicians Treatment Abandonment of physicians indicate that PA issues can lead to patients abandoning recommended treatments Serious Health Risks physicians report that PA issues have led to a serious adverse event for a patient in their care Increased Costs increase in overall healthcare utilization, leading to higher costs and more visits Better Prior Authorization = Better Opportunities Medication is not always the best path, but when it is, you want to ensure you get it authorized
published data show no significant increase in ACTH, cortisol, or prolactin
Patients with commercial insurance and patients paying for Wegovy out-of-pocket may be eligible for the savings offer
Schedules may vary depending on the research model, and frequent monitoring is recommended to adjust dosing based on experimental endpoints
So, now, we have several medications in the class of GLP-1 agonists designed for diabetes and some specifically designed for weight loss (even though they are exactly the same and just differ in dosing)
Semaglutide is FDA-approved for multiple indications: as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus